BB Good human data, but mixed outcomes or surrogate markers. How we grade →Pooled trial data · 14 trials, 1,422 people
Predicting the effects of supplemental EPA and DHA on the omega-3 index
R Walker, K Jackson, N Tintle, G Shearer, A Bernasconi, S Masson et al. The American Journal of Clinical Nutrition. 2019.
- In plain language
- Dose, starting index and chemical form predicted the rise; about 850 mg a day as ethyl esters was predicted to take the index from 4.9% to about 6.5%, and triglyceride forms raised it about 1 point more.
- Limits
- Model of a blood marker, not outcomes; funded in part by OmegaQuant, a testing lab that employed a co-author.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: The Omega-3 Index: what it measures, how supplements move it, and what it does and does not predict
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade →Graded claim: Omega-3 (EPA and DHA): EPA and DHA status
- Source
- doi.org/10.1093/ajcn/nqz161 · PubMed 31396625
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.